Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant.
about
The early stage of bacterial genome-reductive evolution in the hostStructural flexibility in the Burkholderia mallei genomeIdentification of Bacillus anthracis specific chromosomal sequences by suppressive subtractive hybridizationAnimal models for Francisella tularensis and Burkholderia species: scientific and regulatory gaps toward approval of antibiotics under the FDA Animal RuleStructural insights into WcbI, a novel polysaccharide-biosynthesis enzymeContinuing evolution of Burkholderia mallei through genome reduction and large-scale rearrangementsStrategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei.Type VI secretion is a major virulence determinant in Burkholderia malleiInsights into cross-kingdom plant pathogenic bacteriaProtection against Experimental Melioidosis with a Synthetic manno-Heptopyranose Hexasaccharide GlycoconjugateUse of suppression-subtractive hybridization to identify genes in the Burkholderia cepacia complex that are unique to Burkholderia cenocepacia.ATP-binding cassette systems in Burkholderia pseudomallei and Burkholderia mallei.Survival of Burkholderia pseudomallei in water.Host immunity in the protective response to vaccination with heat-killed Burkholderia mallei.Burkholderia mallei cluster 1 type VI secretion mutants exhibit growth and actin polymerization defects in RAW 264.7 murine macrophages.Genetic and phenotypic diversity in Burkholderia: contributions by prophage and phage-like elements.Identification of Burkholderia mallei and Burkholderia pseudomallei adhesins for human respiratory epithelial cells.Dictyostelium discoideum as a model system for identification of Burkholderia pseudomallei virulence factors.Identification of DNA sequences specific for Vibrio vulnificus biotype 2 strains by suppression subtractive hybridization.Delineating the importance of serum opsonins and the bacterial capsule in affecting the uptake and killing of Burkholderia pseudomallei by murine neutrophils and macrophagesNonviable Burkholderia mallei induces a mixed Th1- and Th2-like cytokine response in BALB/c miceGenomic acquisition of a capsular polysaccharide virulence cluster by non-pathogenic Burkholderia isolates.The Madagascar hissing cockroach as a novel surrogate host for Burkholderia pseudomallei, B. mallei and B. thailandensis.Development and validation of a method for purification of mallein for the diagnosis of glanders in equines.Monoclonal antibodies passively protect BALB/c mice against Burkholderia mallei aerosol challenge.Burkholderia thailandensis oacA mutants facilitate the expression of Burkholderia mallei-like O polysaccharides.Contribution of gene loss to the pathogenic evolution of Burkholderia pseudomallei and Burkholderia malleiNovel Burkholderia mallei virulence factors linked to specific host-pathogen protein interactions.Isolation and mutagenesis of a capsule-like complex (CLC) from Francisella tularensis, and contribution of the CLC to F. tularensis virulence in miceUse of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in miceElucidation of the regulon and cis-acting regulatory element of HrpB, the AraC-type regulator of a plant pathogen-like type III secretion system in Burkholderia pseudomallei.Identification of circulating bacterial antigens by in vivo microbial antigen discovery.Melioidosis vaccines.Determination of protein-ligand interactions using differential scanning fluorimetry.Use of the common marmoset to study Burkholderia mallei infectionType III secretion: a virulence factor delivery system essential for the pathogenicity of Burkholderia mallei.Characterization of the Burkholderia pseudomallei K96243 capsular polysaccharide I coding region.Unraveling the B. pseudomallei Heptokinase WcbL: From Structure to Drug Discovery.Burkholderia mallei expresses a unique lipopolysaccharide mixture that is a potent activator of human Toll-like receptor 4 complexes.Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders
P2860
Q21131555-F186DEDE-BD50-49C7-8633-A0D6421804B6Q22066378-3A51048B-B255-421E-8D29-52658C98704CQ24800556-71BA5928-4295-4F42-809F-53F37C58A93FQ26859041-7E8975BE-96BA-4343-8889-EE71D7D83400Q27684860-E26DA8F4-A461-4C4C-858C-ACE99E538089Q28277593-D939572E-60EF-4F89-8124-1BDF01D743ACQ28299584-15C0DDAD-8885-40FB-996A-167F0ECB96FFQ28305456-DD1F6628-1DAF-4A06-ACBC-59D650723B80Q28658951-6C245B17-886C-4E83-B3F6-07A2620710DDQ28829950-62B3F7B7-964A-45DF-939E-2F50BE8B02B6Q33219966-BA7CB8CE-2AC9-4303-A7A5-6160DCFEE82BQ33280317-AFF038FA-6619-4AC4-B2CC-E2589B9A9E78Q33360998-43CAEE1D-89B5-41E3-805B-42529485F15AQ33372589-A5F1C920-4DBC-48BD-9D49-34A9876DC530Q33557901-5CA52EB3-CE18-4E9E-9813-0DBBF3F29C22Q33643800-15D7DF31-6088-46AB-AD06-532DC61D36C7Q33709714-FBCB3FE2-E618-4A9F-A993-805792671ADBQ33845653-E73CE0DD-02BE-4010-8038-C9E07C1D347FQ33995993-D90FC96E-D9CE-4100-BE35-EBD6A9999EC0Q34075114-866219B2-5768-4602-972C-D9E41DBAB472Q34121068-78EE4B4D-152B-4A6F-9D77-625173D74283Q34156158-74F16959-D44D-4DE4-84C4-942564BB0765Q34379527-CBF7A865-B4CB-44B5-92B6-6EE7BA43F92AQ34400057-D4F92328-390B-47C8-9164-5039C80AAA15Q34491887-762250E6-AFF6-467B-AE14-17E9DB400FB3Q34529504-3E68364F-028C-49F0-9BA2-478D2722798DQ34758894-435B9724-7F54-4F93-A2F1-33215DBF6332Q34783879-72DE9A5D-FDF7-442E-A8F8-AA835D4633C4Q34841347-84AE667D-1CCF-4000-8EB8-5BBCF25E2D26Q35009671-8C13B76A-C5F6-4E59-92DE-E647A32C2C99Q35095831-6D4A1F59-B70C-485F-978E-4F3AAD3A8203Q35187007-817646D4-917C-4543-AF4E-95F56088D837Q35193507-73FA18BA-C760-49AD-98D2-5F501D0F1E74Q35303994-2CD58B99-074C-4C50-9314-BA81713B1895Q35364578-B2AED79B-EC05-474E-86BF-B3CC40A15589Q35550224-77F2E3D8-B5AB-477E-88E4-9575E71C92C8Q35805361-95620637-6D57-47D1-B5B7-883BF5B832A3Q35873812-AED7563E-FB07-4FA0-93AB-5889E43FEBA1Q35987326-14A0A95E-80CF-482E-B95D-710D0FB98002Q36164961-0181A280-5589-441B-AF13-0677C67B4223
P2860
Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Identification of a Burkholder ...... sential virulence determinant.
@ast
Identification of a Burkholder ...... sential virulence determinant.
@en
Identification of a Burkholder ...... sential virulence determinant.
@nl
type
label
Identification of a Burkholder ...... sential virulence determinant.
@ast
Identification of a Burkholder ...... sential virulence determinant.
@en
Identification of a Burkholder ...... sential virulence determinant.
@nl
prefLabel
Identification of a Burkholder ...... sential virulence determinant.
@ast
Identification of a Burkholder ...... sential virulence determinant.
@en
Identification of a Burkholder ...... sential virulence determinant.
@nl
P2093
P356
P1476
Identification of a Burkholder ...... sential virulence determinant.
@en
P2093
P304
P356
10.1006/MPAT.2000.0430
P577
2001-05-01T00:00:00Z